Annals of Allergy, Asthma & Immunology DOI: 10.1016/j.anai.2014.07.005
Saba Arshi, MD∗, Morteza Fallahpour, MD fallahpour.morteza at gmail.com , Mohammad Nabavi, MD∗, Mohammad Hasan Bemanian, MD∗, Seyed Ali Javad-Mousavi, MD†, Marzieh Nojomi, MD, MPH‡, Hossein Esmaeilzadeh, MD∗, Rasool Molatefi, MD∗, Mahsa Rekabi, MD∗, Farhad Jalali, PhD∗, Nadieh Akbarpour, PhD∗
Vitamin D is hypothesized to have some roles in innate and adaptive immunity, inflammation reduction, and remodeling; therefore, it is supposed to affect the asthma phenotype, severity, and response to inhaled corticosteroid (ICS).
To explore the synergistic effects of vitamin D supplementation in addition to asthma controllers (ICS or ICS plus long-acting β-agonist) on airway functions.
A randomized clinical trial was conducted in 130 individuals aged 10 to 50 years who lived in Tehran during a 24-week period. Data on age, sex, body mass index, stage of asthma, serum total IgE, history of allergic rhinitis, atopic dermatitis, food allergy, and urticaria were collected. Spirometric parameters (forced expiratory volume in 1 second [FEV1] and ratio of FEV1 to forced vital capacity) and serum vitamin D measurement were obtained before and 8 and 24 weeks after the intervention. Patients were divided in 2 groups randomly.
Both groups received asthma controllers (budesonide or budesonide plus formoterol) according to their stage, but the intervention group received vitamin D supplementation (100,000-U bolus intramuscularly plus 50,000 U orally weekly) in addition to asthma controllers.
FEV1 improved significantly in both groups after 8 weeks, but no significant difference was found between the 2 groups at baseline (P = .20) or after 8 weeks (P = .99); however, a significant improvement was seen in the intervention group in the last 16 weeks, and FEV1 was significantly better in the intervention group than the other group after 24 weeks (P < .001).
Vitamin D supplementation associated with asthma controllers could significantly improve FEV1 in mild to moderate persistent asthma after 24 weeks.
irct.ir Identifier: IRCT201302079608N1.
- Overview Asthma and Vitamin D
- Asthma is not treated by weekly 14,000 IU of vitamin D (proven yet again) July 2014
- Asthma attacks reduced in half if Vitamin D level higher than 42 nanograms – RCT May 2014
- Proof that Vitamin D Works Asthma has been proven to be treated by Vitamin D at least 3 times
The TOP (most read) articles in Breathing and Vitamin D are listed here:
- Asthma treated by daily 50,000 IU of Vitamin D – April 2018
- Traffic pollution increases asthma unless supplement with Vitamin D (mice) June 2018
- The lungs can activate vitamin D locally – a Vitamin D inhaler may help lungs – Aug 2016
- Inhaled vitamin D helped lungs of new-born (rats) – Dec 2016
- Five times less mite allergy when vitamin D added in mid pregnancy and to infant – RCT April 2016
- COPD becoming suddenly worse is 30X more likely if low vitamin D – Dec 2014
- Smoking associated with 9 ng less vitamin D age 40-50 – Nov 2014
- Inflammatory diseases: review of vitamin D, with many tables – May 2014
- Lung, lung cancer, asthma, COPD, and Vitamin D – July 2013
- Severity of adult asthma associated with less vitamin D – Feb 2013
- Acute respiratory infection treated by vitamin D in 6 of 12 clinical trials – review Nov 2012
- Vitamin D Deficiency is a Strong Predictor (4X) of Asthma in Children – Oct 2012
- Just 300 IU daily of vitamin D reduced respiratory infections by 50% – RCT Aug 2012
- Acute lower respiratory infection 5X more frequent with low vitamin D intake – June 2012
- 100 percent of Acute Respiratory Failure patients had low vitamin D - April 2012
- Smoking reduces vitamin D